Safety of ustekinumab and vedolizumab during pregnancy - pregnancy, neonatal and infant outcome: a prospective multicenter study
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F22%3A73615406" target="_blank" >RIV/61989592:15110/22:73615406 - isvavai.cz</a>
Result on the web
<a href="https://academic.oup.com/ecco-jcc/article/16/12/1808/6609344?login=true" target="_blank" >https://academic.oup.com/ecco-jcc/article/16/12/1808/6609344?login=true</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/ecco-jcc/jjac086" target="_blank" >10.1093/ecco-jcc/jjac086</a>
Alternative languages
Result language
angličtina
Original language name
Safety of ustekinumab and vedolizumab during pregnancy - pregnancy, neonatal and infant outcome: a prospective multicenter study
Original language description
Evidence on the safety of newer biologics during pregnancy is limited. We aimed to assess the safety of ustekinumab and vedolizumab treatment during gestation on pregnancy and infant outcome. Furthermore, we evaluated the placental transfer of these agents.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30219 - Gastroenterology and hepatology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Crohns & Colitis
ISSN
1873-9946
e-ISSN
1876-4479
Volume of the periodical
16
Issue of the periodical within the volume
12
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
8
Pages from-to
1808-1815
UT code for WoS article
000821168100001
EID of the result in the Scopus database
2-s2.0-85143551817